Layermune 3

This page contains information on Layermune 3 for veterinary use.
The information provided typically includes the following:
  • Layermune 3 Indications
  • Warnings and cautions for Layermune 3
  • Direction and dosage information for Layermune 3

Layermune 3

This treatment applies to the following species:
Manufacturer: Ceva Biomune

NEWCASTLE-BRONCHITIS VACCINE, Mass. Type, Killed Virus, SALMONELLA ENTERITIDIS BACTERIN

Layermune 3 Indications

This vaccine-bacterin is recommended for use in healthy chickens at least 12 weeks of age as an aid in the prevention of Newcastle disease and infectious bronchitis (Mass. type), and in the reduction of Salmonella enteritidis colonization of the internal organs, including the reproductive tract, and the intestine. Vaccination of breeder pullets should be in accordance with provisions established by the National Poultry Improvement Plan. To prevent interference with pullorum-typhoid feeding, do not vaccinate birds that are to be tested for pullorum-typhoid until testing is complete.

DOSAGE AND DIRECTIONS: The dose is 0.5 ml (1000 doses) or 0.25 ml (2000 doses) per bird and is administered by the subcutaneous route using a 1/4 to 1/2 inch needle. The preferred site is under the skin on the back of the neck midway between the head and body and in a direction away from the head. Do not inject near the head. Do not inject into muscle tissue or neck vertebrae. Prior to use, warm the vaccine-bacterin to 85-90°F (29-32°C). Shake the vaccine-bacterin well before and during use. Use aseptic technique. A repeat vaccination with the Salmonella Enteritidis Bacterin, Layermune SE, is recommended 4 to 6 weeks later.

A primary vaccination with live bronchitis vaccine of the Mass. type is recommended at least four weeks prior to administration of this vaccine-bacterin. Revaccination prior to molt is recommended.

Warning

Do not vaccinate within 42 days before slaughter. Post vaccination reactions may occur and may include swelling or granulomas at the injection site. Also, due to the stress of handling or moving birds, vaccination of hens in lay may result in a drop in egg production.

NOTICE: This vaccine-bacterin has undergone rigid purity, sterility, potency and safety tests and meets Biomune and USDA requirements. However, the user is advised that response to vaccination depends on numerous factors including, but not limited to, storage, handling, aseptic technique and the health and responsiveness of individual chickens.

Layermune 3 Caution

This vaccine-bacterin should be stored, transported and administered in accordance with the directions. This product contains an oil based adjuvant, and accidental injection of this vaccine-bacterin into a human may cause a serious localized reaction. Seek expert medical attention immediately.

DO NOT FREEZE. STORE AT 35-45°F (2-7°C). USE ENTIRE CONTENTS WHEN FIRST OPENED.

FOR VETERINARY USE ONLY

NON-RETURNABLE PRODUCT

BIOMUNE CO., 8906 Rosehill Road, Lenexa, Kansas 66215 USA

Phone: (913) 894-0230

U.S. Vet Lic. No. 368

1000 Doses (500 ml) - 0.50 ml dose

624

2000 Doses (500 ml) - 0.25 ml dose

623

NAC No.: 11290094

CEVA BIOMUNE
8906 ROSEHILL ROAD, LENEXA, KS, 66215
Telephone:   913-894-0230
Fax:   913-894-0236
Website:   www.ceva-us.com
Every effort has been made to ensure the accuracy of the Layermune 3 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-09-05

(web5)